Naltrexone Treatment Centers in Michigan

No. You can pay out of pocket, use Healthy Michigan Plan if eligible, or qualify for sliding-scale rates at many Michigan federally qualified health centers. Uninsured patients should still call naltrexone providers to ask about grant-funded slots and state-funded treatment vouchers.

For methadone, once SAMHSA take-home criteria are met, the monthly OTP fee covers both in-clinic and take-home doses. For buprenorphine, the clinic fee typically covers the 30-day prescription filled at a Michigan pharmacy. For long-acting naltrexone (Vivitrol), the monthly dose is administered at the visit and included in that visit fee.

Yes. Healthy Michigan Plan covers the mandated counseling component for MAT — individual therapy, group sessions, and care coordination — at participating Michigan clinics. Reimbursement for peer-support specialists is also available under the state plan.

Marketplace silver plans in Michigan typically have $4,000–$7,500 individual deductibles. MAT visits accumulate toward the deductible until it is met; after that, coinsurance typically drops to 20–30%. HSA and HRA funds can cover MAT out-of-pocket costs.

For methadone, SAMHSA’s 2024 final rule allows OTPs in Michigan to grant up to 28 days of take-home doses once clinical-stability criteria are met. For buprenorphine, 30-day prescriptions are standard and 90-day fills are permitted in many Michigan plans. Long-acting naltrexone is a single monthly injection, so no take-home supply applies.

Methadone tapering generally takes longer than buprenorphine because of its long half-life and higher cumulative-dose equilibrium. Most Michigan clinicians taper methadone over 6–12 months or longer. Buprenorphine tapers often complete in 3–6 months for stable patients.

Call a naltrexone clinic directly, SAMHSA’s national helpline (1-800-662-4357), or 988 for urgent help. Most Michigan naltrexone providers offer same-day or next-business-day intake; the intake visit includes an assessment and your first dose or prescription.

Most patients feel calm relief of withdrawal rather than euphoria. Mild drowsiness is common the first day; avoid driving or operating machinery until you know how you react. Severe sedation is rare and warrants a call to the Michigan clinic.

Long-term opioid-agonist therapy (methadone, buprenorphine) can lower testosterone in some men and affect menstruation in some women. Annual hormone panels are reasonable. Switching medications or adjusting dose resolves most cases; endocrinology referral is available in Michigan for persistent issues.

Many MAT-exposed infants are observed 72–96 hours for NOWS signs before discharge. Some require NICU care for withdrawal management. Modern Michigan hospitals practice Eat, Sleep, Console protocols that reduce NICU stays and emphasize rooming-in with the mother.

Yes — counseling records are protected by 42 CFR Part 2 and HIPAA. The counselor cannot disclose your MAT status or session content to family, employer, or law enforcement without your specific written consent or a narrowly tailored court order.

If you use insurance, the insurer sees billed services (including MAT). They cannot share that with your employer or family. If you strongly value privacy from insurance, self-pay is the only fully insulated option.